288 related articles for article (PubMed ID: 25797901)
1. SALTIRE-RAAVE: targeting calcific aortic valve disease LDL-density-radius theory.
Rajamannan NM; Greve AM; Moura LM; Best P; Wachtell K
Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):355-67. PubMed ID: 25797901
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.
Cowell SJ; Newby DE; Prescott RJ; Bloomfield P; Reid J; Northridge DB; Boon NA;
N Engl J Med; 2005 Jun; 352(23):2389-97. PubMed ID: 15944423
[TBL] [Abstract][Full Text] [Related]
3. Statins for calcific aortic valve stenosis: into oblivion after SALTIRE and SEAS? An extensive review from bench to bedside.
Hermans H; Herijgers P; Holvoet P; Verbeken E; Meuris B; Flameng W; Herregods MC
Curr Probl Cardiol; 2010 Jun; 35(6):284-306. PubMed ID: 20451759
[TBL] [Abstract][Full Text] [Related]
4. The effect of statins on valve function and calcification in aortic stenosis: A meta-analysis.
Zhao Y; Nicoll R; He YH; Henein MY
Atherosclerosis; 2016 Mar; 246():318-24. PubMed ID: 26828749
[TBL] [Abstract][Full Text] [Related]
5. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community.
Bellamy MF; Pellikka PA; Klarich KW; Tajik AJ; Enriquez-Sarano M
J Am Coll Cardiol; 2002 Nov; 40(10):1723-30. PubMed ID: 12446053
[TBL] [Abstract][Full Text] [Related]
6. [Statins in aortic stenosis].
Dejanović J; Ivanov I
Med Pregl; 2009; 62 Suppl 3():101-4. PubMed ID: 19702126
[TBL] [Abstract][Full Text] [Related]
7. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.
Côté C; Pibarot P; Després JP; Mohty D; Cartier A; Arsenault BJ; Couture C; Mathieu P
Heart; 2008 Sep; 94(9):1175-80. PubMed ID: 17932090
[TBL] [Abstract][Full Text] [Related]
8. Current Problems in Cardiology. Statins for calcific aortic valve stenosis: into oblivion after SALTIRE and SEAS? An extensive review from bench to bedside. Foreword.
Rahimtoola SH
Curr Probl Cardiol; 2010 Jun; 35(6):281. PubMed ID: 20451758
[No Abstract] [Full Text] [Related]
9. Statin treatment of patients with calcific aortic valve disease modulates extracellular adenosine metabolism on the cell surface of the aortic valve.
Kutryb-Zajac B; Jablonska P; Hebanowska A; Lango R; Rogowski J; Slominska EM; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1389-1399. PubMed ID: 32126886
[TBL] [Abstract][Full Text] [Related]
10. The lipid theory in the pathogenesis of calcific aortic stenosis.
Parisi V; Leosco D; Ferro G; Bevilacqua A; Pagano G; de Lucia C; Perrone Filardi P; Caruso A; Rengo G; Ferrara N
Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):519-25. PubMed ID: 25816732
[TBL] [Abstract][Full Text] [Related]
11. Targeting vasoactive peptides for managing calcific aortic valve disease.
Peltonen T; Ohukainen P; Ruskoaho H; Rysä J
Ann Med; 2017 Feb; 49(1):63-74. PubMed ID: 27585243
[TBL] [Abstract][Full Text] [Related]
12. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.
Novaro GM; Tiong IY; Pearce GL; Lauer MS; Sprecher DL; Griffin BP
Circulation; 2001 Oct; 104(18):2205-9. PubMed ID: 11684632
[TBL] [Abstract][Full Text] [Related]
13. Statin use for nonrheumatic calcific aortic valve stenosis: a review with meta-analysis.
De Vecchis R; Di Biase G; Esposito C; Ciccarelli A; Cioppa C; Giasi A; Ariano C; Cantatrione S
J Cardiovasc Med (Hagerstown); 2013 Aug; 14(8):559-67. PubMed ID: 23032960
[TBL] [Abstract][Full Text] [Related]
14. Statin therapy of calcific aortic stenosis: hype or hope?
Liebe V; Brueckmann M; Borggrefe M; Kaden JJ
Eur Heart J; 2006 Apr; 27(7):773-8. PubMed ID: 16399777
[TBL] [Abstract][Full Text] [Related]
15. Aortic sclerosis, aortic stenosis and lipid-lowering therapy.
Rosenhek R; Baumgartner H
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):385-90. PubMed ID: 18327997
[TBL] [Abstract][Full Text] [Related]
16. Aortic valve stenosis and lipid-lowering therapy: the state of the art.
Bonadei I; Vizzardi E; D'aloia A; Gelsomino S; De Cicco G; Lorusso R; Dei Cas L
Panminerva Med; 2013 Dec; 55(4):391-5. PubMed ID: 24434347
[TBL] [Abstract][Full Text] [Related]
17. [Elevated HDL is the main negative risk factor for coronary artery disease in the elderly patient with calcific aortic valve disease].
Bordalo AD; Nobre AL; Dantas M; Cravino J
Rev Port Cardiol; 2012 Jun; 31(6):415-24. PubMed ID: 22609029
[TBL] [Abstract][Full Text] [Related]
18. Calcific aortic stenosis and statin therapy: a new insight.
Roncalli J; Carrié D; Galinier M
Int J Cardiol; 2009 Jan; 131(2):275-6; author reply 276-7. PubMed ID: 17825931
[TBL] [Abstract][Full Text] [Related]
19. What is the ultimate test that lowering lipoprotein(a) is beneficial for cardiovascular disease and aortic stenosis?
Hung MY; Tsimikas S
Curr Opin Lipidol; 2014 Dec; 25(6):423-30. PubMed ID: 25340480
[TBL] [Abstract][Full Text] [Related]
20. Intensive lipid-lowering therapy for patients with aortic stenosis.
Pedersen TR
Am J Cardiol; 2008 Dec; 102(11):1571-6. PubMed ID: 19026317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
